FDA Releases Updated Guidance on Impurities in Drug Products for Generic Drug Applications

Summary

The Food and Drug Administration (FDA) has released an updated guidance for industry on impurities in drug products for abbreviated new drug applications (ANDAs), aligning with the International Conference on Harmonisation (ICH) Q3B(R) guidance, following the initial release in December 1998 and a revision in August 2006.